BR0308027A - Processo para preparação de um derivado de fenilalanina e seus intermediários - Google Patents

Processo para preparação de um derivado de fenilalanina e seus intermediários

Info

Publication number
BR0308027A
BR0308027A BR0308027-7A BR0308027A BR0308027A BR 0308027 A BR0308027 A BR 0308027A BR 0308027 A BR0308027 A BR 0308027A BR 0308027 A BR0308027 A BR 0308027A
Authority
BR
Brazil
Prior art keywords
preparing
phenylalanine derivative
intermediates
halogen atom
group
Prior art date
Application number
BR0308027-7A
Other languages
English (en)
Inventor
Isao Inoue
Toru Kuroda
Ryuzo Yoshioka
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of BR0308027A publication Critical patent/BR0308027A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE UM DERIVADO DE FENILALANINA E SEUS INTERMEDIáRIOS". A presente invenção refere-se a um processo para preparação de um novo derivado de fenilalanina de fórmula (I), na qual X^ 1^ é um átomo de halogênio, X^ 2^ é um átomo de halogênio, Q é um grupo de fórmula -CH~ 2~- ou -(CH~ 2~)~ 2~- e y é um grupo alquila inferior, ou um sal farmaceuticamente aceitável do mesmo, que tem excelente atividade inibitória contra adesão celular mediada por integrina <244>4, e um intermediário útil no processo.
BR0308027-7A 2002-02-28 2003-02-27 Processo para preparação de um derivado de fenilalanina e seus intermediários BR0308027A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002052605 2002-02-28
PCT/JP2003/002181 WO2003072536A1 (en) 2002-02-28 2003-02-27 A process for preparing a phenylalanine derivative and intermediates thereof

Publications (1)

Publication Number Publication Date
BR0308027A true BR0308027A (pt) 2004-12-28

Family

ID=27764341

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308027-7A BR0308027A (pt) 2002-02-28 2003-02-27 Processo para preparação de um derivado de fenilalanina e seus intermediários

Country Status (22)

Country Link
US (1) US7476758B2 (pt)
EP (1) EP1478619B1 (pt)
KR (1) KR100681224B1 (pt)
CN (2) CN100522930C (pt)
AR (1) AR038624A1 (pt)
AT (1) ATE495147T1 (pt)
AU (1) AU2003208618B2 (pt)
BR (1) BR0308027A (pt)
CA (1) CA2476022C (pt)
DE (1) DE60335704D1 (pt)
ES (1) ES2359302T3 (pt)
HK (1) HK1069382A1 (pt)
IL (1) IL163429A (pt)
MX (1) MXPA04008359A (pt)
MY (1) MY140707A (pt)
NO (1) NO331001B1 (pt)
NZ (1) NZ534957A (pt)
PL (1) PL211046B1 (pt)
RU (1) RU2280641C2 (pt)
TW (1) TWI327996B (pt)
WO (1) WO2003072536A1 (pt)
ZA (1) ZA200406747B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
EP1389618B1 (en) 2001-04-27 2011-06-15 Eisai R&D Management Co., Ltd. Pyrazolo 1,5-a pyridines and medicines containing the same
US7122580B2 (en) * 2002-08-09 2006-10-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
ATE426600T1 (de) 2002-10-22 2009-04-15 Eisai R&D Man Co Ltd 7-phenylpyrazolopyridinverbindungen
US7176216B2 (en) 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
US7459472B2 (en) * 2003-08-08 2008-12-02 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
AR054129A1 (es) 2005-06-09 2007-06-06 Uc S A Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
MY152687A (en) 2008-04-15 2014-10-31 Eisai R&D Man Co Ltd 3-phenylpyrazolo[5,1-b]thiazole compound
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
WO2011048091A1 (en) * 2009-10-21 2011-04-28 Glaxo Group Limited Process for preparing a phenylalanine derivative
CA3115830C (en) 2018-10-30 2023-09-12 Gilead Sciences, Inc. Compounds for inhibition of .alpha.4.beta.7 integrin
PE20211866A1 (es) 2018-10-30 2021-09-21 Gilead Sciences Inc Derivados de quinolina como inhibidores de la integrina alfa4beta7
AU2019373244B2 (en) 2018-10-30 2022-05-26 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
KR102652797B1 (ko) 2018-10-30 2024-04-02 길리애드 사이언시즈, 인코포레이티드 알파4베타7 인테그린의 억제를 위한 화합물
JP7491996B2 (ja) 2019-08-14 2024-05-28 ギリアード サイエンシーズ， インコーポレイテッド α４β７インテグリンの阻害のための化合物

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508251A1 (de) 1985-03-08 1986-09-11 Merck Patent Gmbh, 6100 Darmstadt Dipeptide
GB8625941D0 (en) 1986-10-30 1986-12-03 Sandoz Ltd Substituted alpha-amino acids
NZ228855A (en) 1988-04-25 1992-08-26 Hoffmann La Roche Tyrosine analogues and peptides containing them especially cholecystokinin (cck) analogues
JP2868914B2 (ja) 1991-03-04 1999-03-10 日本ケミファ株式会社 α−アミノ酸誘導体
US5294632A (en) 1991-05-01 1994-03-15 Ciba-Geigy Corporation Phosphono/biaryl substituted dipetide derivatives
US5455260A (en) 1993-05-21 1995-10-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aliphatic amino bis-aryl squalene synthase inhibitors
RU2126418C1 (ru) 1993-11-01 1999-02-20 Циба-Гейги Джапан Димитед Антагонисты рецепторов эндотелина
US5432186A (en) 1993-11-16 1995-07-11 Ciba-Geigy Corporation Cyclic amino acid derivatives
IL112759A0 (en) 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
US5703106A (en) 1994-03-28 1997-12-30 Japat Ltd. Antagonists of endothelin receptors
US5505244A (en) * 1994-08-08 1996-04-09 Thumann; Pierce A. Retractable covering for a door opening
DE69528197T2 (de) 1994-12-14 2003-06-05 Santen Pharmaceutical Co Ltd Neue 1,3-dialkylharnstoff-derivate
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
WO1996033170A1 (en) 1995-04-21 1996-10-24 Novarits Ag N-aroylamino acid amides as endothelin inhibitors
GB9518553D0 (en) 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
JPH0987291A (ja) 1995-09-26 1997-03-31 Wakamoto Pharmaceut Co Ltd 新規なアラニン誘導体
WO1997011960A1 (en) 1995-09-28 1997-04-03 Japat Ltd. Antagonists of endothelin receptors
IT1277737B1 (it) 1995-12-28 1997-11-12 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
US5849293A (en) * 1996-01-11 1998-12-15 Cornell Research Foundation, Inc. Use of human transferrin in controlling insulin levels
FR2745571B1 (fr) 1996-03-04 1998-06-19 Inst Nat Sante Rech Med Nouveaux derives soufres comportant une liaison amide, leur procede de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant
AU706855B2 (en) 1996-04-24 1999-06-24 Medivir Uk Ltd Substrates and inhibitors of proteolytic enzymes
JPH1036587A (ja) * 1996-07-24 1998-02-10 Chisso Corp 二軸延伸ポリプロピレンフィルム
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
US6291511B1 (en) 1997-05-29 2001-09-18 Merck & Co., Inc. Biarylalkanoic acids as cell adhesion inhibitors
EP1001764A4 (en) 1997-05-29 2005-08-24 Merck & Co Inc Heterocyclic amides as cell adhesion inhibitors
US6221888B1 (en) 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
WO1998054207A1 (en) 1997-05-30 1998-12-03 Celltech Therapeutics Limited Anti-inflammatory tyrosine derivatives
US6127341A (en) 1997-06-20 2000-10-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
AU8163398A (en) 1997-06-23 1999-01-04 Pharmacia & Upjohn Company Inhibitors of alpha4beta1mediated cell adhesion
BR9812111A (pt) 1997-07-31 2000-07-18 Elan Pharm Inc Dipeptìdeo e compostos correlatos que inibem adesão de leucócito mediada por vla-4
ATE327245T1 (de) 1997-07-31 2006-06-15 Elan Pharm Inc Verbindungen mit einer 4-amino-phenylalaningruppe,die die vla-4 vermittelte adhäsion von leukozyten inhibieren
ZA986827B (en) 1997-07-31 2000-05-02 Athena Neurosciences Inc Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4.
PL338506A1 (en) 1997-07-31 2000-11-06 Elan Pharm Inc Compounds inhibiting adhesion of leucocytes occuring through the mediation of vla-4
AR016133A1 (es) 1997-07-31 2001-06-20 Wyeth Corp Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
US6489300B1 (en) 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
CN1265673A (zh) 1997-07-31 2000-09-06 伊兰药品公司 抑制由vla－4介导的白细胞粘着的二肽化合物
EP1001975A1 (en) 1997-07-31 2000-05-24 Elan Pharmaceuticals, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4
US6229011B1 (en) 1997-08-22 2001-05-08 Hoffman-La Roche Inc. N-aroylphenylalanine derivative VCAM-1 inhibitors
US6455550B1 (en) 1997-08-22 2002-09-24 Hoffmann-La Roche Inc. N-alkanoylphenylalanine derivatives
US5988980A (en) * 1997-09-08 1999-11-23 General Electric Company Blade assembly with splitter shroud
US6069163A (en) 1997-10-21 2000-05-30 Merck & Co., Inc. Azapeptide acids as cell adhesion inhibitors
US6191171B1 (en) 1997-11-20 2001-02-20 Merck & Co., Inc. Para-aminomethylaryl carboxamide derivatives
US6090841A (en) 1997-11-21 2000-07-18 Merck & Co., Inc. Substituted pyrrole derivatives as cell adhesion inhibitors
US6645939B1 (en) 1997-11-24 2003-11-11 Merck & Co., Inc. Substituted β-alanine derivatives as cell adhesion inhibitors
WO1999026615A1 (en) 1997-11-24 1999-06-03 Merck & Co., Inc. Cyclic amino acid derivatives as cell adhesion inhibitors
US6197794B1 (en) 1998-01-08 2001-03-06 Celltech Therapeutics Limited Phenylalanine derivatives
AU1890399A (en) 1998-01-19 1999-08-02 Takara Shuzo Co., Ltd. Substances capable of inducing apoptosis
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
DE69919334T2 (de) 1998-02-26 2005-08-04 Celltech Therapeutics Ltd., Slough Phenylalaninderivate als inhibitoren von alpha4 integrinen
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
AU8059598A (en) 1998-06-11 1999-12-30 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
US6685617B1 (en) 1998-06-23 2004-02-03 Pharmacia & Upjohn Company Inhibitors of α4β1 mediated cell adhesion
NL1009753C2 (nl) 1998-07-28 2000-02-01 Royalty Bugaboo S A R L Buggy.
DE69915692T2 (de) 1998-12-22 2005-02-10 Tanabe Seiyaku Co., Ltd. Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
WO2000043369A1 (en) 1999-01-22 2000-07-27 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by vla-4
GB2354440A (en) 1999-07-20 2001-03-28 Merck & Co Inc Aryl amides as cell adhesion inhibitors
US6420418B1 (en) 1999-08-16 2002-07-16 Merck & Co., Inc. Heterocycle amides as cell adhesion inhibitors
WO2001014328A2 (en) 1999-08-20 2001-03-01 Merck & Co., Inc. Substituted ureas as cell adhesion inhibitors
IL148544A0 (en) 1999-09-24 2002-09-12 Genentech Inc Tyrosine derivatives
MY129000A (en) * 2000-08-31 2007-03-30 Tanabe Seiyaku Co INHIBITORS OF a4 MEDIATED CELL ADHESION
US6489511B1 (en) * 2001-08-16 2002-12-03 Eastman Kodak Company Azomethine compound manufacture

Also Published As

Publication number Publication date
ATE495147T1 (de) 2011-01-15
EP1478619A1 (en) 2004-11-24
KR20040091665A (ko) 2004-10-28
CA2476022C (en) 2008-07-15
MY140707A (en) 2010-01-15
NO20044087L (no) 2004-09-27
TW200303854A (en) 2003-09-16
ZA200406747B (en) 2005-08-31
US20050165107A1 (en) 2005-07-28
CN100522930C (zh) 2009-08-05
HK1069382A1 (en) 2005-05-20
CN100480233C (zh) 2009-04-22
AR038624A1 (es) 2005-01-19
RU2280641C2 (ru) 2006-07-27
AU2003208618A1 (en) 2003-09-09
CN1817853A (zh) 2006-08-16
WO2003072536A1 (en) 2003-09-04
US7476758B2 (en) 2009-01-13
DE60335704D1 (de) 2011-02-24
PL371386A1 (en) 2005-06-13
MXPA04008359A (es) 2004-11-26
AU2003208618B2 (en) 2008-06-19
PL211046B1 (pl) 2012-04-30
IL163429A (en) 2012-07-31
EP1478619B1 (en) 2011-01-12
ES2359302T3 (es) 2011-05-20
TWI327996B (en) 2010-08-01
RU2004128935A (ru) 2006-02-20
CN1646482A (zh) 2005-07-27
CA2476022A1 (en) 2003-09-04
NZ534957A (en) 2006-11-30
NO331001B1 (no) 2011-09-05
KR100681224B1 (ko) 2007-02-09

Similar Documents

Publication Publication Date Title
BR0308027A (pt) Processo para preparação de um derivado de fenilalanina e seus intermediários
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
WO2001014330A3 (en) Phenylpiperazines as serotonin reuptake inhibitors
CA2405486A1 (fr) Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
BR0309012A (pt) Uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para a preparação de um composto
TW200800974A (en) Glucuronate salt of a piperazine compound
AU2003257493A1 (en) Pleuromutilin derivatives as antimicrobbials
BR0012489A (pt) Composto, composição farmacêutica, uso de um composto, e, kit para a contracepção masculina
DK1153017T3 (da) Bicykliske forbindelser og deres anvendelse som integrinreceptorligander
PT865498E (pt) Processo para a preparacao de ciclodepsipeptideos com 24 atomos no anel substituidos contendo acido aril-lactico
MY129831A (en) Process for preparing aripiprazole
BR9810657A (pt) &#34;processo de preparação de um per-hidroisoindol substituìdo&#34;
MA27143A1 (fr) Utilisation de derives de 2-amino-4- pyridylmethyl-thiazoline comme inhibiteurs de no-synthase inductible
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
PT1303514E (pt) Processo para preparacao de azacicloalcanoilaminotiazoles
PT1102765E (pt) Processo para a sintese de derivados de (1h)-benzo¬c|quinolizin-3-onas
BR9911794A (pt) Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos
PT1210359E (pt) Processo para a preparacao de derivados do acido 3-amino-biliar
BR9810896A (pt) Processo de preparação de derivados aminas de alquiloxifuranona, compostos provenientes desse processo e utilização desses compostos
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
BR0212839A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes e composição farmacêutica contendo os mesmos
PT1230252E (pt) Derivados de beta-d-5-tioxilose processo de preparacao e utilizacao em terapeutica
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
BR9507857A (pt) Um processo para a preparação de derivados de 5,6-Diidroxi-2-amino-1,2,3,4-tetraidronaftaleno

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MITSUBISHI TANABE PHARMA CORPORATION (JP)

Free format text: ALTERADO DE: TANABE SEIYAKU CO., LTD.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.